$SMG

Scotts Miracle-Gro (SMG) expects $100M in commodity headwinds for fiscal 2027, planning 4% price increases and $35M in supply chain savings. Adjusted gross margin is expected to expand, though likely at the lower end of its target. Inventory levels are up slightly, and the $55M acquisition of Black Kow is expected to boost sales. The company aims to reduce net debt to 3-3.5x EBITDA by fiscal 2029, with $275M in free cash flow expected for fiscal 2027.

UBS kept its Buy rating on Scotts Miracle Gro and raised its price target to $77 from $70, citing a 16% upside from the Nov 5 close. Recent analyst targets range from $67 to $76.

JP Morgan kept its Neutral rating on Scotts Miracle-Gro but reduced its price target from $70 to $67, a 4.3% decrease. The new target is close to the stock's recent close of $66.38.

Scotts Miracle-Gro (SMG) reported Q4 2026 earnings, highlighting 18% growth in Miracle-Gro Organic sales and a 16% increase in pre-emergent units. The company acquired Black Kow, expanded e-commerce to 13% of sales, and plans 2%-4% net sales growth for 2027 with adjusted EPS of $4.70-$4.90. SMG emphasized innovation, operational efficiencies, and strategic investments.

SCOTTS MIRACLE-GRO CO (SMG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 The Scotts Miracle-Gro Company NEWS ScottsMiracle-Gro Reports Strong Fiscal 2026 Full-Year Results GAAP and Non-GAAP Gross Margin Expands, Non-GAAP Adjusted EPS Exceeds Guidance Fiscal 2027 guidance calls for continued top-line and bottom-line growth MARYSVILLE, Ohio

Wells Fargo raised its price target for Scotts Miracle-Gro (NYSE:SMG) to $71, citing manageable headwinds and potential margin expansion. The stock is up 10% year-to-date and 21.5% over the past year, trading at $62.24. UBS and Stifel also recently updated their price targets and ratings for SMG.

Scotts Miracle-Gro's EVP & Chief Strategy Officer, Christopher J. Hagedorn, will depart on September 30, 2026. The company's SEC filing details a separation agreement including 24 months of severance pay, outplacement services, and equity treatment. Specific bonus and incentive payouts are also outlined.

SCOTTS MIRACLE-GRO CO (SMG) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 29, 2026, The Scotts Miracle-Gro Company (the “Company”) reported that Christopher J. Hagedorn, the Company’s for

Analysts updated ratings and price targets for several companies. Notable changes include Crocs upgraded to Overweight with a target of $139, IBM's target raised to $238, Microsoft's target increased to $675, and Morgan Stanley's target cut to $185. Other companies received mixed recommendations and target adjustments.

UBS upgraded Scotts Miracle-Gro (SMG) to Buy with a $70 price target, down from $78, citing 40% upside potential. The stock has fallen 25.7% since August, trading near 52-week lows. UBS sees earnings growth through 2027, driven by revenue growth and productivity initiatives. SMG reported Q3 2026 earnings of $2.82 per share, beating estimates, and raised its full-year EPS outlook.